Successful treatment with paclitaxel/carboplatin chemotherapy in advanced adenocarcinoma of the urinary tract producing
carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125.
Neem leaf glycoprotein enhances
carcinoembryonic antigen presentation of dendritic cells to T and B cells for induction of antitumor immunity by allowing generation of immune effector / memory response.
Similarly, the association between persistently elevated
carcinoembryonic antigen following colorectal surgery and resection of colorectal liver metastases has also been well documented (11, 12).
Pulmonary
carcinoembryonic antigen (CEA) production in patients with end-stage lung diseases submitted to lung transplantation.
A reappraisal of the value of
carcinoembryonic antigen in the management of patients with various neoplasms.
A blood test called
Carcinoembryonic antigen (CEA) is often used to find out if the tumour is back or find how well it has responded to treatment.
In such cases, a second transvaginal ultrasound study was done and tumor markers were measured, including CA 125, CA 19-9,
carcinoembryonic antigen, alpha-fetoprotein, and lactate dehydrogenase fraction.
These include prostate specific antigen (PSA), associated with prostate cancer, and
carcinoembryonic antigen (CEA) which is found in 90 per cent of colon cancers and 40 per cent of breast cancers.
Patients with colorectal cancer are usually monitored by quantifying
carcinoembryonic antigen (CEA) in serum in order to detect relapse earlier.
The serum
carcinoembryonic antigen (CEA) and CA19-9 levels were normal; CA125 was 71.
In addition to targeting the
carcinoembryonic antigen (CEA or CEACAM5) expressed by many human cancers, TF2 has been engineered to recognize a small peptide that carries radioactivity.
The serum levels of
carcinoembryonic antigen and carbohydrate antigen 19-9 were within the normal reference range.
